Device Trial Radar · NCT04882358
Safety & Feasibility of DSR TherApy in Heart FAiluRe pAtients With Persistent Congestion
Last checked: Nov 19, 2026Latest source record: Nov 9, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
24
Planned (sponsor's estimate)
Start
May 27, 2021
Primary completion
Aug 31, 2022
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Sequana Medical N.V.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Feasibility and safety study of the alfapump DSR system in the treatment of volume overloaded heart failure subjects receiving high doses of loop diuretics. Up to 24 subjects will be enrolled in up to 3 centres in Republic of Georgia, and randomized into 2 parallel treatment arms. Once implanted with the alfapump DSR system they will undergo DSR therapy in 2 phases: intensive treatment phase followed by maintenance treatment phase.
Conditions
- Heart Failure
- Volume Overload
Interventions
ALFAPUMP DSR (DIRECT SODIUM REMOVAL) SYSTEMDevice
Infusion of sodium free Dextrose 10% into peritoneal cavity to remove sodium and fluid using principles of peritoneal dialysis; sodium and ultrafiltrate will be evacuated to the bladder by the alfapump
SGLT2 inhibitorDrug
treatment with a standard dose of SGLT-2 inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety - Treatment related SAETime frame: up to day 156
- Safety - Device related SAETime frame: up to day 156
- Safety - Procedure related SAETime frame: up to day 156
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Israeli-Georgian Medical Research Clinic Helsicore
Tbilisi, Georgia
Tbilisi Heart & Vascular Clinic
Tbilisi, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.